{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:14:28Z","timestamp":1772003668488,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1006\/exnr.2000.7583","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"162-170","source":"Crossref","is-referenced-by-count":49,"title":["Botulinum A Toxin: Dysport Improvement of Biological Availability"],"prefix":"10.1006","volume":"168","author":[{"given":"Hans","family":"Bigalke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wohlfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Irmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Dengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2000.7583_RF1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/014107689208500906","article-title":"Botulinum toxin treatment of spasmodic torticollis","volume":"85","author":"Anderson","year":"1992","journal-title":"J. R. Soc. Med."},{"key":"10.1006\/exnr.2000.7583_RF2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.53.8.640","article-title":"Botulinum toxin treatment in spasmodic torticollis","volume":"53","author":"Blackie","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1006\/exnr.2000.7583_RF3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000116936","article-title":"Effectiveness of botulinum toxin in the treatment of spasmodic torticollis","volume":"33","author":"Boghen","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.46.1.26","article-title":"Botulinum toxin therapy, immunologic resistance, and problems with available materials","volume":"46","author":"Borodic","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hed.2880140108","article-title":"Botulinum A toxin for spasmodic torticollis: Multiple vs single injection points per muscles","volume":"14","author":"Borodic","year":"1992","journal-title":"Head Neck"},{"key":"10.1006\/exnr.2000.7583_RF6","series-title":"Therapy with Botulinum Toxin","first-page":"331","article-title":"Hemifacial spasm: Evaluation and management, with emphasis of botulinum toxin therapy","author":"Borodic","year":"1994"},{"key":"10.1006\/exnr.2000.7583_RF7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00867425","article-title":"Botulinum toxin in cervical dystonia: Low dosage with electromyographic guidance","volume":"242","author":"Brans","year":"1995","journal-title":"J. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF8","first-page":"493","article-title":"Botulinum toxin: Dangerous terminology errors","volume":"86","author":"Brin","year":"1991","journal-title":"J. R. Soc. Med."},{"key":"10.1006\/exnr.2000.7583_RF9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Move. Disord."},{"key":"10.1006\/exnr.2000.7583_RF10","first-page":"38","article-title":"Observations on the isolated phrenic nerve diaphragm preparation in the rat","volume":"1","author":"B\u00fclbring","year":"1946","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/exnr.2000.7583_RF11","first-page":"604","article-title":"Lokale Injektionsbehandlung mit Botulinum-Toxin A bei Blepharospasmus, Meige-Syndrom und Spasmus hemifacialis","volume":"61","author":"Ceballos-Baumann","year":"1990","journal-title":"Nervenarzt"},{"key":"10.1006\/exnr.2000.7583_RF12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2007-1017982","article-title":"Die Behandlung von Dystonien mit Botulinumtoxin","volume":"21","author":"Dengler","year":"1994","journal-title":"Akt. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00656720","article-title":"Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates is dependent on nerve stimulation and temperature","volume":"399","author":"Dreyer","year":"1983","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1006\/exnr.2000.7583_RF14","first-page":"17","article-title":"Clinical bioequivalence of the current preparations of botulinum toxin","volume":"2","author":"Durif","year":"1995","journal-title":"Eur. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","article-title":"Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in humans","volume":"224","author":"Eleopra","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2000.7583_RF16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00839203","article-title":"Management of blepharospasm and hemifacial spasm","volume":"239","author":"Elston","year":"1992","journal-title":"J. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.39.1.80","article-title":"Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis","volume":"39","author":"Gelb","year":"1989","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF18","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/AEM.58.10.3426-3428.1992","article-title":"Stabilization of botulinum toxin type A during lyophilization","volume":"58","author":"Goodnough","year":"1992","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1006\/exnr.2000.7583_RF19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: Neutralizing and nonneutralizing antibodies\u2014Therapeutic consequences","volume":"147","author":"G\u00f6schel","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.870110211","article-title":"Response of botulinum toxin F in seronegative botulinum toxin A-resistant patients","volume":"2","author":"Greene","year":"1996","journal-title":"Move. Disord."},{"key":"10.1006\/exnr.2000.7583_RF21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40","author":"Greene","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00500299","article-title":"Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin","volume":"311","author":"Habermann","year":"1980","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1006\/exnr.2000.7583_RF23","first-page":"719","article-title":"Potency equivalence of botulinum toxin preparations","volume":"87","author":"Hambleton","year":"1994","journal-title":"J. R. Soc. Med."},{"key":"10.1006\/exnr.2000.7583_RF24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.40.2.277","article-title":"Botulinum toxin injections for cervical dystonia","volume":"40","author":"Jancovic","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF25","first-page":"1186","article-title":"Therapeutic uses of botulinum toxin","volume":"17","author":"Jankovic","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.2000.7583_RF26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.1991.00530240057020","article-title":"Clinical correlates of response to botulinum toxin injections","volume":"48","author":"Jankovic","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/WNL.43.4.834","article-title":"Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia","volume":"43","author":"Jankovic","year":"1993","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes","volume":"14","author":"Lange","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1006\/exnr.2000.7583_RF29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.870060210","article-title":"Treatment of idiopathic spasmodic torticollis with botulinum toxin A: A double-blind study on twenty-three patients","volume":"6","author":"Lorentz","year":"1991","journal-title":"Move. Disord."},{"key":"10.1006\/exnr.2000.7583_RF30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.54.9.813","article-title":"A double blind trial of botulinum toxin A in torticollis, with one year follow-up","volume":"54","author":"Moore","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1006\/exnr.2000.7583_RF31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.65.6.924","article-title":"Depletion of neutralising antibodies resensitises a secondary nonresponder to botulinum A neurotoxin","volume":"65","author":"Naumann","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1006\/exnr.2000.7583_RF32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0041-0101(92)90864-2","article-title":"Clostridial neurotoxins\u2014Proposal of a common nomenclature","volume":"30","author":"Niemann","year":"1992","journal-title":"Toxicon"},{"key":"10.1006\/exnr.2000.7583_RF33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"Nuessgen","year":"1997","journal-title":"Graefe's Arch. Clin. Exp. Ophtalmol."},{"key":"10.1006\/exnr.2000.7583_RF34","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.38.11.1780","article-title":"Neuromuscular effects distant from the site of botulinum neurotoxin injection","volume":"38","author":"Olney","year":"1988","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00839206","article-title":"Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients","volume":"239","author":"Poewe","year":"1992","journal-title":"J. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0140-6736(90)90263-5","article-title":"Dose standardisation of botulinum toxin","volume":"335","author":"Schantz","year":"1990","journal-title":"Lancet"},{"key":"10.1006\/exnr.2000.7583_RF37","series-title":"Therapy with Botulinum Toxin","first-page":"41","article-title":"Preparation and characterization of botulinum toxin type A for human treatment","author":"Schantz","year":"1994"},{"key":"10.1006\/exnr.2000.7583_RF38","first-page":"16","article-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction","volume":"212","author":"Simpson","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.2000.7583_RF39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection: Type B compared with type A","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1006\/exnr.2000.7583_RF40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","article-title":"A pilot study on the use of botulinum toxin in spasmodic torticollis","volume":"12","author":"Tsui","year":"1985","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1006\/exnr.2000.7583_RF41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/exnr.2000.7583_RF42","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1006\/exnr.2000.7583_RF43","first-page":"231","article-title":"Dose standardization of botulinum toxin","volume":"78","author":"Van den Bergh","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2000.7583_RF44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00004951","article-title":"Botulinum A toxins: Units versus units","volume":"355","author":"Wohlfahrt","year":"1997","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1006\/exnr.2000.7583_RF45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","article-title":"Treatment of hemifacial spasm with botulinum toxin","volume":"15","author":"Yoshimura","year":"1992","journal-title":"Muscle Nerv."},{"key":"10.1006\/exnr.2000.7583_RF46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","article-title":"Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance","volume":"43","author":"Zuber","year":"1993","journal-title":"Neurology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600975836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488600975836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T04:20:52Z","timestamp":1680582052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488600975836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0014488600975836"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2000.7583","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}